(Q39413034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Anton Neschadim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

M Scaife

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

B C Y Au

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J C M Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S Devine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

E Scheid

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

C-J Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

O Lopez-Perez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

D H Fowler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Foley

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J A Medin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

12 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

24-34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Treatment of chronic lymphocytic leukemia with genetically targeted autologous T cells: case report of an unforeseen adverse event in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

A guanylate kinase/HSV-1 thymidine kinase fusion protein enhances prodrug-mediated cell killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Coexpression of guanylate kinase with thymidine kinase enhances prodrug cell killing in vitro and suppresses vascular smooth muscle cell proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Engineered human tmpk/AZT as a novel enzyme/prodrug axis for suicide gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

In vivo toxicity of foscarnet and zidovudine given alone or in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

A novel anti-HIV dextrin-zidovudine conjugate improving the pharmacokinetics of zidovudine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Immunohistochemical characterization of transgenic mice highly expressing human lysosomal alpha-galactosidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

The PDL1-PD1 axis converts human TH1 cells into regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Correction in trans for Fabry disease: expression, secretion and uptake of alpha-galactosidase A in patient-derived cells driven by a high-titer recombinant retroviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Preselective gene therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

inferred from DOI database lookup

7 January 2021

based on heuristic

Modifying Human Thymidylate Kinase to Potentiate Azidothymidine Activation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.210

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2011.210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22241175%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference